Singapore markets closed

Cabaletta Bio, Inc. (CABA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.48+0.14 (+1.91%)
At close: 04:00PM EDT
7.50 +0.02 (+0.28%)
After hours: 05:24PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-51,171
-67,675
-52,975
-46,289
-33,339
-
Depreciation & amortisation
1,054
1,426
1,178
733
354
-
Stock-based compensation
6,920
11,343
6,897
5,804
4,388
-
Change in working capital
-1,390
101
-4,299
5,581
1,708
-
Accounts payable
-489
1,675
-28
975
555
-
Other working capital
-47,052
-54,236
-48,833
-35,275
-27,405
-
Other non-cash items
3,544
2,478
3,042
-
-
-
Net cash provided by operating activities
-44,764
-53,549
-46,380
-34,109
-26,770
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,288
-687
-2,453
-1,166
-635
-
Purchases of investments
-49,764
-84,264
-49,764
0
-11,097
-
Sales/maturities of investments
26,000
62,500
25,000
7,165
3,751
-
Net cash used for investing activities
-26,052
-22,451
-27,217
5,999
-7,981
-
Cash flows from financing activities
Common stock issued
13,543
185,202
32,855
48,253
29
-
Common stock repurchased
-
-
-
-
-192
-1,293
Other financing activities
-
-
-
-
-
-1,293
Net cash used provided by (used for) financing activities
13,719
187,631
32,982
48,903
-24
-
Net change in cash
-57,097
111,631
-40,615
20,793
-34,775
-
Cash at beginning of period
118,260
81,607
122,222
101,429
136,204
-
Cash at end of period
61,163
193,238
81,607
122,222
101,429
-
Free cash flow
Operating cash flow
-44,764
-53,549
-46,380
-34,109
-26,770
-
Capital expenditure
-2,288
-687
-2,453
-1,166
-635
-
Free cash flow
-47,052
-54,236
-48,833
-35,275
-27,405
-